Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

Morning review

Thursday 08.01.2026
Companies

Morning topics

M&A machine running smoothly
Accumulate
(previously: Accumulate)
Metsä Board: Ongelmia jäi vino pino myös tälle vuodelle
Reduce
(previously: Reduce)
Oriola kertoi jakelukeskuksen investointisuunnitelman ja valotti uuden strategian avainteemoja
Accumulate
YIT teki täsmähankinnan rata- ja raiderakentamisessa
Reduce
Kreate won a contract in a metro project in Sweden
Reduce
Herantis' latest analysis reveals HER-096's activity in central nervous system
Accumulate
Market review
OMX Helsinki 25
5,831
+1.12%
OMX Stockholm 30
2,963
+2.12%
OMX Copenhagen 25
1,898
-0.05%
DAX
25,122
+0.92%
STOXX Europe 600
605.1
-0.04%
SSE Comp.
4,088
+0.04%
Nikkei 225
51,276
-1.32%
EUR/USD
1.168
-0.01%
Gainers
Springvest8.00 EUR
+14.94%
Exel Composites0.60 EUR
+13.64%
Metsä Board A5.30 EUR
+9.05%
Outokumpu4.83 EUR
+5.78%
Faron Pharmaceuticals2.24 EUR
+5.66%
Losers
Nanoform Finland0.97 EUR
-15.65%
Summa Defence1.90 EUR
-12.84%
Eagle Filters Group A0.07 EUR
-11.69%
Sotkamo Silver0.27 EUR
-11.07%
Digitalist Group1.98 EUR
-8.30%
Upcoming events
Jan 14
1 event
Jan 20
1 event
Jan 21
2 events
Jan 23
2 events
Webcasts of the day
Herantis Pharma Plc, Phase 1b biomarker data webcast
08.01.2026 klo 12.00
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.